Camber Spine Technologies received FDA 510(k) clearance for the Siconus™ SI Joint Fixation System for the treatment of sacroiliac disease, as a complement to Prolix™ custom-machined allograft.
Siconus was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education.
Camber Spine received its first 510(K) in 1H13, for the TLS 5.0 Interbody Cage. Most recently (early 3Q16), the company announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion device, occurring in a 2-level lumbar procedure.
Camber Spine Technologies received FDA 510(k) clearance for the Siconus™ SI Joint Fixation System for the treatment of sacroiliac disease, as a complement to Prolix™ custom-machined allograft.
Siconus was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education.
Camber Spine received its...
Camber Spine Technologies received FDA 510(k) clearance for the Siconus™ SI Joint Fixation System for the treatment of sacroiliac disease, as a complement to Prolix™ custom-machined allograft.
Siconus was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education.
Camber Spine received its first 510(K) in 1H13, for the TLS 5.0 Interbody Cage. Most recently (early 3Q16), the company announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion device, occurring in a 2-level lumbar procedure.
Copy to clipboard 
